Cell-free fetal DNA test can be primary screen for aneuoploidy-risk pregnancies, says Ob-Gyn society Prenatal testing based on fetal DNA floating in a mother’s bloodstream got a nod from a professional medical society this week, which could benefit companies selling the diagnostic tools.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.